P253 Transient versus sustained antibodies to infliximab: Possibility to overcome low titer antibody responses by dose optimisation

N. Van de Casteele

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

N. Van de Casteele

L. Cuypers

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

L. Cuypers

S. Singh

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

S. Singh

S. Hauenstein

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

S. Hauenstein

L. Ohrmund

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

L. Ohrmund

E. Chuang

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

E. Chuang

P. Rutgeerts

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

P. Rutgeerts

A. Gils

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

A. Gils

S. Vermeire

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

S. Vermeire